SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maddalena Frau, Maria M. Simile, Maria L. Tomasi, Maria I. Demartis, Lucia Daino, Maria A. Seddaiu, Stefania Brozzetti, Claudio F. Feo, Giovanni Massarelli, Giuliana Solinas, Francesco Feo, Ju-Seog Lee, Rosa M. Pascale, An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis, Cellular Oncology, 2012,

    CrossRef

  2. 2
    Hong Yang, Xing-Xing He, Qi-Long Song, Man Chen, Jin Li, Meng-Yi Wang, Jin-Ling Yu, Jin-Jian Yao, Li-Feng Liu, Ju-Sheng Lin, Association of Ephrin receptor A3 gene polymorphism with susceptibility to chronic severe hepatitis B, Hepatology Research, 2012, 42, 6
  3. 3
    Diego F. Calvisi, Maddalena Frau, Maria L. Tomasi, Francesco Feo, Rosa M. Pascale, Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012, 1826, 1, 215

    CrossRef

  4. 4
    Kyu-Hwan Na, Hyun-Jung Lee, Jong-Ho Choi, Jung-Woo Eun, Suk-Woo Nam, Tae-Ki Yoon, Gi-Jin Kim, Dynamic alterations in integrin α4 expression by hypoxia are involved in trophoblast invasion during early implantation, Journal of Cellular Biochemistry, 2012, 113, 2
  5. 5
    Zeynep Coban, Michelle Craig Barton, Integrative genomics: Liver regeneration and hepatocellular carcinoma, Journal of Cellular Biochemistry, 2012, 113, 7
  6. 6
    Claudia Augello, Valentina Vaira, Luca Caruso, Annarita Destro, Marco Maggioni, Young Nyun Park, Marco Montorsi, Roberto Santambrogio, Massimo Roncalli, Silvano Bosari, MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma, Liver International, 2012, 32, 5
  7. 7
    Chun-Ming Wong, Carmen Chak-Lui Wong, Joyce Man-Fong Lee, Dorothy Ngo-Yin Fan, Sandy Leung-Kuen Au, Irene Oi-Lin Ng, Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis, Hepatology, 2012, 55, 5
  8. 8
    Paul C. Schröder, Víctor Segura, José Ignacio Riezu, Bruno Sangro, José M. Mato, Jesús Prieto, Enrique Santamaría, Fernando J. Corrales, A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma, Functional & Integrative Genomics, 2011, 11, 3, 419

    CrossRef

  9. 9
    Peng Gao, Carmen Chak-Lui Wong, Edmund Kwok-Kwan Tung, Joyce Man-Fong Lee, Chun-Ming Wong, Irene Oi-Lin Ng, Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis, Journal of Hepatology, 2011, 54, 6, 1177

    CrossRef

  10. 10
    Luca Di Tommaso, Annarita Destro, Valentina Fabbris, Gaia Spagnuolo, Anna Laura Fracanzani, Silvia Fargion, Marco Maggioni, Carlo Patriarca, Roberto Maria Macchi, Michela Quagliuolo, Mauro Borzio, Massimo Iavarone, Angelo Sangiovanni, Massimo Colombo, Massimo Roncalli, Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma, Hepatology, 2011, 53, 5
  11. 11
    Hyun Goo Woo, Eun Sung Park, Snorri S. Thorgeirsson, Yoon Jun Kim, Exploring genomic profiles of hepatocellular carcinoma, Molecular Carcinogenesis, 2011, 50, 4
  12. 12
    Jeong Kyu Kim, Kwang Hwa Jung, Ji Heon Noh, Jung Woo Eun, Hyun Jin Bae, Hong Jian Xie, Ja-June Jang, Jae Chun Ryu, Won Sang Park, Jung Young Lee, Suk Woo Nam, Identification of characteristic molecular signature for volatile organic compounds in peripheral blood of rat, Toxicology and Applied Pharmacology, 2011, 250, 2, 162

    CrossRef

  13. 13
    Tobias Flecken, Hans Christian Spangenberg, Robert Thimme, Immunobiology of hepatocellular carcinoma, Langenbeck's Archives of Surgery, 2011, 397, 5, 673

    CrossRef

  14. 14
    Bu-Yeo Kim, Kyung-Suk Suh, Je-Geun Lee, Seon Rang Woo, In-Chul Park, Sun-Hoo Park, Chul Ju Han, Sang-Bum Kim, Sook-Hyang Jeong, Young Il Yeom, Suk-Jin Yang, Chang-Min Kim, Su Jin Cho, Young Do Yoo, Myung-Haing Cho, Ja June Jang, Dong Wook Choi, Kee-Ho Lee, Integrated Analysis of Prognostic Gene Expression Profiles from Hepatitis B Virus-Positive Hepatocellular Carcinoma and Adjacent Liver Tissue, Annals of Surgical Oncology, 2011,

    CrossRef

  15. 15
    Siyuan Zheng, William P Tansey, Scott W Hiebert, Zhongming Zhao, Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma, BMC Medical Genomics, 2011, 4, 1, 62

    CrossRef

  16. 16
    H. van Malenstein, J. van Pelt, C. Verslype, Molecular classification of hepatocellular carcinoma anno 2011, European Journal of Cancer, 2011, 47, 12, 1789

    CrossRef

  17. 17
    Zenta Walther, Dhanpat Jain, Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance, Pathology Research International, 2011, 2011, 1

    CrossRef

  18. 18
    Yun Ku Cho, Jin Wook Chung, Yoonjung Kim, Hyun Je Cho, Soo Hyun Yang, Radiofrequency ablation of high-grade dysplastic nodules, Hepatology, 2011, 54, 6
  19. 19
    Ming-Chin Yu, Yun-Shien Lee, Sey-En Lin, Hsiang-Yao Wu, Tse-Ching Chen, Wei-Chen Lee, Miin-Fu Chen, Chi-Neu Tsai, Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and Osteopontin, Annals of Surgical Oncology, 2011,

    CrossRef

  20. 20
    Kai Breuhahn, Gregory Gores, Peter Schirmacher, Strategies for hepatocellular carcinoma therapy and diagnostics: Lessons learned from high throughput and profiling approaches, Hepatology, 2011, 53, 6
  21. 21
    Josep M. Llovet, Valerie Paradis, Masatoshi Kudo, Jessica Zucman-Rossi, Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma, Liver Transplantation, 2011, 17, S2
  22. 22
    Hui Dong, Wen-Ming Cong, Zhi-Hong Xian, Zhong-Zheng Zhu, Using loss of heterozygosity of microsatellites to distinguish high-grade dysplastic nodule from early minute hepatocellular carcinoma, Experimental and Molecular Pathology, 2011, 91, 2, 578

    CrossRef

  23. 23
    Massimo Roncalli, Luca Di Tommaso, Mauro Borzio, Young Nyun Park, Practical Hepatic Pathology: A Diagnostic Approach, 2011,

    CrossRef

  24. 24
    Li Gong, Yan-Hong Li, Qin Su, Xia Chu, Wei Zhang, Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes, Histopathology, 2010, 56, 5
  25. 25
    Augusto Villanueva, Beatriz Minguez, Alejandro Forner, Maria Reig, Josep M. Llovet, Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy, Annual Review of Medicine, 2010, 61, 1, 317

    CrossRef

  26. 26
    Kellie J. Archer, Valeria R. Mas, Daniel G. Maluf, Robert A. Fisher, High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma, Molecular Genetics and Genomics, 2010, 283, 4, 341

    CrossRef

  27. 27
    S.W. French, Molecular events in hepatic preneoplasia: A review, Experimental and Molecular Pathology, 2010, 88, 2, 219

    CrossRef

  28. 28
    Kwang Hwa Jung, Jeong Kyu Kim, Ji Heon Noh, Jung Woo Eun, Hyun Jin Bae, Hong Jian Xie, Young Min Ahn, Won Sang Park, Jung Young Lee, Suk Woo Nam, Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma, Journal of Cellular Biochemistry, 2010, 110, 3
  29. 29
    Y. Pei, T. Zhang, V. Renault, X. Zhang, An overview of hepatocellular carcinoma study by omics-based methods, Acta Biochimica et Biophysica Sinica, 2009, 41, 1, 1

    CrossRef

  30. 30
    Jennifer Watkins, Charles Balabaud, Paulette Bioulac-Sage, Dinesh Sharma, Amar Dhillon, Hepatocellular adenoma in advanced-stage fatty liver disease, European Journal of Gastroenterology & Hepatology, 2009, 21, 8, 932

    CrossRef

  31. 31
    Olga Lorenz, Wolfram Parzefall, Eveline Kainzbauer, Helge Wimmer, Bettina Grasl-Kraupp, Christopher Gerner, Rolf Schulte-Hermann, Proteomics reveals acute pro-inflammatory and protective responses in rat Kupffer cells and hepatocytes after chemical initiation of liver cancer and after LPS and IL-6, PROTEOMICS - Clinical Applications, 2009, 3, 8
  32. 32
    Takeaki Ishizawa, Noriyoshi Fukushima, Junji Shibahara, Koichi Masuda, Sumihito Tamura, Taku Aoki, Kiyoshi Hasegawa, Yoshifumi Beck, Masashi Fukayama, Norihiro Kokudo, Real-time identification of liver cancers by using indocyanine green fluorescent imaging, Cancer, 2009, 115, 11
  33. 33
    Jung Woo Eun, Seung Jun Kwack, Ji Heon Noh, Kwang Hwa Jung, Jeong Kyu Kim, Hyun Jin Bae, Hongjian Xie, Jae Chun Ryu, Young Min Ahn, Jin-Hye Min, Won Sang Park, Jung Young Lee, Gyu Seek Rhee, Suk Woo Nam, Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine, Toxicology and Applied Pharmacology, 2009, 237, 1, 91

    CrossRef

  34. 34
    Ping Guan, Andrew Olaharski, Mark Fielden, Nigel Roome, Yvonne Dragan, Joseph Sina, Biomarkers of carcinogenicity and their roles in drug discovery and development, Expert Review of Clinical Pharmacology, 2008, 1, 6, 759

    CrossRef

  35. 35
    Keiko Furuta, Sayaka Sato, Taeko Yamauchi, Shinichi Kakumu, Changes in intrahepatic gene expression profiles from chronic hepatitis to hepatocellular carcinoma in patients with hepatitis C virus infection, Hepatology Research, 2008, 38, 7
  36. 36
    Perumal Vivekanandan, Om V Singh, High-dimensional biology to comprehend hepatocellular carcinoma, Expert Review of Proteomics, 2008, 5, 1, 45

    CrossRef

  37. 37
    Susie A. Lee, Coral Ho, Ritu Roy, Cynthia Kosinski, Mohini A. Patil, Aaron D. Tward, Jane Fridlyand, Xin Chen, Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer, Hepatology, 2008, 47, 4
  38. 38
    Augusto Villanueva, Sara Toffanin, Josep M Llovet, Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps, Current Opinion in Oncology, 2008, 20, 4, 444

    CrossRef

  39. 39
    Chun-Ming Wong, Irene O. L. Ng, Molecular pathogenesis of hepatocellular carcinoma, Liver International, 2008, 28, 2
  40. 40
    Josep M. Llovet, Jordi Bruix, Novel advancements in the management of hepatocellular carcinoma in 2008, Journal of Hepatology, 2008, 48, S20

    CrossRef

  41. 41
    Elisa Wurmbach, Ying-bei Chen, Greg Khitrov, Weijia Zhang, Sasan Roayaie, Myron Schwartz, Isabel Fiel, Swan Thung, Vincenzo Mazzaferro, Jordi Bruix, Erwin Bottinger, Scott Friedman, Samuel Waxman, Josep M. Llovet, Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma, Hepatology, 2007, 45, 4
  42. 42
    Nikki PY Lee, S T Cheung, Ronnie TP Poon, Sheung-Tat Fan, John M Luk, Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma, Biomarkers in Medicine, 2007, 1, 2, 273

    CrossRef

  43. 43
    Prodromos Hytiroglou, Young Nyun Park, Glenn Krinsky, Neil D. Theise, Hepatic Precancerous Lesions and Small Hepatocellular Carcinoma, Gastroenterology Clinics of North America, 2007, 36, 4, 867

    CrossRef

  44. 44
    Massimo Roncalli, Mauro Borzio, Luca Di Tommaso, Hepatocellular dysplastic nodules, Hepatology Research, 2007, 37,
  45. 45
    Shinichi Aishima, Yunosuke Nishihara, Yousuke Kuroda, Kenichi Taguchi, Tomohiro Iguchi, Akinobu Taketomi, Yoshihiko Maehara, Masazumi Tsuneyoshi, Histologic Characteristics and Prognostic Significance in Small Hepatocellular Carcinoma With Biliary Differentiation, The American Journal of Surgical Pathology, 2007, 31, 5, 783

    CrossRef

  46. 46
    Jiezhong Chen, Robert Seviour, Medicinal importance of fungal β-(1→3), (1→6)-glucans, Mycological Research, 2007, 111, 6, 635

    CrossRef

  47. 47
    S N Metodieva, Molecular Pathogenesis of Hepatocellular Carcinoma, Balkan Journal of Medical Genetics, 2007, 10, 2, 15

    CrossRef

  48. 48
    Shinichi Aishima, Yousuke Kuroda, Yunosuke Nishihara, Tomohiro Iguchi, Kenichi Taguchi, Akinobu Taketomi, Yoshihiko Maehara, Masazumi Tsuneyoshi, Proposal of Progression Model for Intrahepatic Cholangiocarcinoma: Clinicopathologic Differences Between Hilar Type and Peripheral Type, The American Journal of Surgical Pathology, 2007, 31, 7, 1059

    CrossRef

  49. 49
    Ruben Raphael Plentz, Young Nyun Park, André Lechel, Haeryoung Kim, Friederike Nellessen, Britta Heike Eva Langkopf, Ludwig Wilkens, Annarita Destro, Barbara Fiamengo, Michael Peter Manns, Massimo Roncalli, Karl Lenhard Rudolph, Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis, Hepatology, 2007, 45, 4
  50. 50
    Josep M. Llovet, Yingbei Chen, Elisa Wurmbach, Sasan Roayaie, M. Isabel Fiel, Myron Schwartz, Swan N. Thung, Gregory Khitrov, Weijia Zhang, Augusto Villanueva, Carlo Battiston, Vincenzo Mazzaferro, Jordi Bruix, Samuel Waxman, Scott L. Friedman, A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis, Gastroenterology, 2006, 131, 6, 1758

    CrossRef

  51. 51
    Cho-Rok Jung, Jinsang Yoo, Ye Jin Jang, Sangsoo Kim, In-Sun Chu, Young Il Yeom, Jong Young Choi, Dong-Soo Im, Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo, Hepatology, 2006, 43, 5
  52. 52
    J-S Lee, S S Thorgeirsson, Comparative and integrative functional genomics of HCC, Oncogene, 2006, 25, 27, 3801

    CrossRef

  53. 53
    Snorri S. Thorgeirsson, Genomic Decoding of Hepatocellular Carcinoma, Gastroenterology, 2006, 131, 4, 1344

    CrossRef

  54. 54
    Nathalie Guedj, Delphine Dargere, Françoise Degos, Jean Louis Janneau, Dominique Vidaud, Jacques Belghiti, Pierre Bedossa, Valerie Paradis, Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion, Laboratory Investigation, 2006, 86, 9, 951

    CrossRef

  55. 55
    Louis Libbrecht, Tamara Severi, David Cassiman, Sara Vander Borght, Jacques Pirenne, Frederik Nevens, Chris Verslype, Jos van Pelt, Tania Roskams, Glypican-3 Expression Distinguishes Small Hepatocellular Carcinomas From Cirrhosis, Dysplastic Nodules, and Focal Nodular Hyperplasia-like Nodules, The American Journal of Surgical Pathology, 2006, 30, 11, 1405

    CrossRef

  56. 56
    J. F. Blanc, Paulette Bioulac-Sage, Ch. Balabaud, Les lésions précancéreuses sur foie cirrhotique et non cirrhotique, Acta Endoscopica, 2006, 36, 3, 325

    CrossRef

  57. 57
    Li Nan, Fawzia Bardag-Gorce, Yong Wu, Jun Li, Barbara A. French, Samuel W. French, Mallory body forming cells express the preneoplastic hepatocyte phenotype, Experimental and Molecular Pathology, 2006, 80, 2, 109

    CrossRef

  58. 58
    Snorri S. Thorgeirsson, Ju-Seog Lee, Joe W. Grisham, Molecular prognostication of liver cancer: End of the beginning, Journal of Hepatology, 2006, 44, 4, 798

    CrossRef

  59. 59
    Jian-Hua Luo, Baoguo Ren, Sergei Keryanov, George C. Tseng, Uma N. M. Rao, Satdarshan P. Monga, Steven Strom, Anthony J. Demetris, Michael Nalesnik, Yan P. Yu, Sarangarajan Ranganathan, George K. Michalopoulos, Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas, Hepatology, 2006, 44, 4
  60. 60
    M Levrero, Viral hepatitis and liver cancer: the case of hepatitis C, Oncogene, 2006, 25, 27, 3834

    CrossRef

  61. 61
    Gary C. Kanel, Liver, Gallbladder, and Extrahepatic Bile Ducts, The Cancer Handbook,
  62. 62
    Morris Sherman, Primary Malignant Neoplasms of the Liver,